secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0000950170-24-016790
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q4 GAAP loss $1.50/share; adj EPS $0.32; 2024 EBITDA guidance $200-220M
--------------------------------------------------------------------------------

- GAAP diluted loss from continuing ops $1.50 vs income $0.29 a year ago; $168.3M non-cash impairment.
- Adj EPS $0.32 (down from $0.47); net revenue $496M (-3.4% YoY); same-unit revenue -1.5%.
- Q4 adjusted EBITDA $50.8M (vs $66.5M); full-year adj EBITDA $200.4M (vs $241M).
- Preliminary 2024 adj EBITDA guidance $200-220M, roughly flat to down from 2023.
- Net AR $272.3M; total debt $628M; no revolver borrowings; cash from ops $72.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017024016790/0000950170-24-016790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017024016790/md-20240220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-016790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer